Consistently, infarct size and myocardial fibrosis levels were reduced in mice with ATF3 downregulation, while SPHK1 overexpression decreased the anti‐fibrotic effect of ATF3 downregulation in MI mice (Figure 6E). The gene discussed is ATF3; the disease is myocardial infarction.